Joseph Jenrette to Aged
This is a "connection" page, showing publications Joseph Jenrette has written about Aged.
Connection Strength
0.235
-
Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy. Am J Surg. 2010 Feb; 199(2):204-9.
Score: 0.028
-
High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas. J Neurooncol. 2009 Jul; 93(3):343-8.
Score: 0.027
-
Patient satisfaction and quality of life after MammoSite breast brachytherapy. Am J Surg. 2008 Oct; 196(4):545-8.
Score: 0.027
-
Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy. 2008 Oct-Dec; 7(4):305-9.
Score: 0.026
-
The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma. Eur J Obstet Gynecol Reprod Biol. 2008 Dec; 141(2):163-8.
Score: 0.026
-
Definitive radiotherapy for medically inoperable early-stage serous and clear cell uterine carcinoma. Radiat Med. 2007 Dec; 25(10):536-40.
Score: 0.025
-
Chest wall dose in MammoSite breast brachytherapy: radiobiologic estimations of late complication risk based on dose-volume considerations. Brachytherapy. 2005; 4(4):259-63.
Score: 0.020
-
Ultrasound-guided tandem placement for low-dose-rate brachytherapy in advanced cervical cancer minimizes risk of intraoperative uterine perforation. Ultrasound Obstet Gynecol. 2011 Feb; 37(2):241-4.
Score: 0.008
-
Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):21-9.
Score: 0.008
-
A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme. J Neurosurg. 2010 Aug; 113(2):192-8.
Score: 0.008
-
Mammographic surveillance after MammoSite breast brachytherapy: analysis of architectural patterns and additional interventions. Am J Clin Oncol. 2007 Dec; 30(6):574-9.
Score: 0.006
-
Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys. 2007 Jun 01; 68(2):354-8.
Score: 0.006
-
GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis. Neurosurgery. 2006 Apr; 58(4):701-9; discussion 701-9.
Score: 0.006
-
Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience. Int J Radiat Oncol Biol Phys. 2005 Jan 01; 61(1):169-74.
Score: 0.005
-
Dynamic stereotactic radiosurgery: the Charleston program: a report on the first 150 patients. J S C Med Assoc. 1998 May; 94(5):218-21.
Score: 0.003
-
Combined modality therapy in the treatment of epidermoid carcinoma of the anus at the Medical University of South Carolina. J S C Med Assoc. 1993 Jul; 89(7):333-6.
Score: 0.002
-
Primary malignant extragonadal germ cell tumors. An analysis of the effect of the effect of radiotherapy. Cancer. 1990 Jun 15; 65(12):2681-5.
Score: 0.002
-
Epidermoid carcinoma of the anus. Surg Gynecol Obstet. 1982 Nov; 155(5):745-51.
Score: 0.001